Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Blackledge

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|August 16, 1986
Avoiding ifosfamide/mesna encephalopathyC A Meanwell, K A Kelly, G Blackledge
British Journal of Cancer|April 1, 1989
Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trialsG Blackledge, F Lawton, C Redman, et al.
Gynecologic Oncology|January 1, 1990
A five-drug alternating chemotherapy regimen for patients with advanced epithelial ovarian cancerF Lawton, C Meanwell, J Mould, et al.
Immunology|July 1, 1982
Lectin-binding characteristics of human natural killer cellsB M Vose, G Blackledge, D Crowther, et al.
Clinical Radiology|March 1, 1980
Computed tomography (CT) in the staging of patients with Hodgkin's Disease: a report on 136 patientsG Blackledge, J J Best, D Crowther, et al.
Clinical Oncology|September 1, 1979
A study of gastro-intestinal lymphomaG Blackledge, H Bush, O G Dodge, et al.
Archives of Disease in Childhood|April 1, 1979
Diagnosis and management of folate deficiency in low birthweight infantsM K Strelling, D G Blackledge, H B Goodall
Radiology|February 1, 1983
Abdomino-pelvic computed tomography in the management of ovarian carcinomaR J Johnson, G Blackledge, B Eddleston, et al.
International Journal of Bio-Medical Computing|January 1, 1980
Computerised acquisition and analysis of flow cytometric dataG Blackledge, R Swindell, B W Hodgson, et al.
European Journal of Cancer|April 1, 1981
Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-GuerinN Thatcher, G Blackledge, M K Palmer, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|August 16, 1986
Avoiding ifosfamide/mesna encephalopathyC A Meanwell, K A Kelly, G Blackledge
British Journal of Cancer|April 1, 1989
Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trialsG Blackledge, F Lawton, C Redman, et al.
Gynecologic Oncology|January 1, 1990
A five-drug alternating chemotherapy regimen for patients with advanced epithelial ovarian cancerF Lawton, C Meanwell, J Mould, et al.
Immunology|July 1, 1982
Lectin-binding characteristics of human natural killer cellsB M Vose, G Blackledge, D Crowther, et al.
Clinical Radiology|March 1, 1980
Computed tomography (CT) in the staging of patients with Hodgkin's Disease: a report on 136 patientsG Blackledge, J J Best, D Crowther, et al.
Clinical Oncology|September 1, 1979
A study of gastro-intestinal lymphomaG Blackledge, H Bush, O G Dodge, et al.
Archives of Disease in Childhood|April 1, 1979
Diagnosis and management of folate deficiency in low birthweight infantsM K Strelling, D G Blackledge, H B Goodall
Radiology|February 1, 1983
Abdomino-pelvic computed tomography in the management of ovarian carcinomaR J Johnson, G Blackledge, B Eddleston, et al.
International Journal of Bio-Medical Computing|January 1, 1980
Computerised acquisition and analysis of flow cytometric dataG Blackledge, R Swindell, B W Hodgson, et al.
European Journal of Cancer|April 1, 1981
Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-GuerinN Thatcher, G Blackledge, M K Palmer, et al.
Pageof 10